Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Veronika Sárosi"'
Autor:
Gabriella Gálffy, Géza Tamás Szabó, Lilla Tamási, Veronika Müller, Judit Moldvay, Veronika Sárosi, Anna Kerpel-Fronius, Tamás Kardos, Edit Csada, Zsolt Pápai-Székely, Zoltán Szász, Zsolt Király, Gábor Hódi, Zsuzsanna Kovács, Éva Balogh, Krisztina Andrea Kovács, Miklós Darida, Viktória Buga, György Rokszin, Zsolt Abonyi-Tóth, Zoltán Kiss, Zoltán Vokó, Krisztina Bogos
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
ObjectiveHungary has repeatedly been shown to have the highest cancer-related mortality and incidence in Europe. Despite lung cancer being the most abundant malignant diagnosis in Hungary, numerous concerns have been raised recently regarding the bia
Externí odkaz:
https://doaj.org/article/9bde8f083408482c872f58d4f50c4120
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Diagnostic bronchoscopy is a minimally invasive procedure that plays a crucial role in the diagnosis and management of various respiratory conditions. This paper explores the advancements in technology that have revolutionized the field and focuses o
Externí odkaz:
https://doaj.org/article/95f6b9a1ca3b4e269e050c8849287e16
Autor:
Zoltán Kiss, Gabriella Gálffy, Veronika Müller, Judit Moldvay, Veronika Sárosi, Zsolt Pápai-Székely, Edit Csada, Anna Kerpel-Fronius, Zsolt Király, Zoltán Szász, Gábor Hódi, Zoltán Polányi, Krisztina Kovács, Eugenia Karamousouli, Kata Knollmajer, Tamás G. Szabó, Andrea Berta, Zoltán Vokó, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, Lilla Tamási, Krisztina Bogos
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19
Externí odkaz:
https://doaj.org/article/af41d80cfb264262bce0e68d6b8a2c77
Autor:
Zolta´n Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Kata Knollmajer, Máté Várnai, Krisztina Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, István Kenessey, András Weber, Péter Nagy, Petra Freyler-Fadgyas, Miklós Szócska, Péter Szegner, Lászlóné Hilbert, Gabriella Branyiczkiné Géczy, György Surján, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy, Zoltán Polányi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed LC with those who were
Externí odkaz:
https://doaj.org/article/dc1a39dc32514d11b8d8fffbd26a0f45
Autor:
Eszter Bencze, Krisztina Bogos, Andrea Kohánka, László Báthory-Fülöp, Veronika Sárosi, Erzsébet Csernák, Nóra Bittner, Zsombor Melegh, Erika Tóth
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
EGFR mutation in non-small cell lung cancer (NSCLC) offers a potential therapeutic target for tyrosine kinase inhibitor (TKI) therapy. The majority of these cases, however eventually develop therapy resistance, mainly by acquiring EGFR T790M mutation
Externí odkaz:
https://doaj.org/article/791ae1e67c614efcaf1a1b0756e5936c
Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
Autor:
Emoke Papp, Anita Steib, Elhusseiny MM Abdelwahab, Judit Meggyes-Rapp, Laszlo Jakab, Gabor Smuk, Erzsebet Schlegl, Judit Moldvay, Veronika Sárosi, Judit E Pongracz
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background Despite improved screening techniques, diagnosis of lung cancer is often late and its prognosis is poor. In the present study, in vitro chemosensitivity of solid tumours and pleural effusions of lung adenocarcinomas were analysed and compa
Externí odkaz:
https://doaj.org/article/0ec02656f1d24dbaa9b72704827f65dc
Autor:
Zsolt Markóczy, Veronika Sárosi, Iveta Kudaba, Gabriella Gálffy, Ülkü Yilmaz Turay, Ahmet Demirkazik, Gunta Purkalne, Attila Somfay, Zsolt Pápai-Székely, Erzsébet Rásó, Gyula Ostoros
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Erlotinib is approved for the first line treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer. Since the number of prospective studies in Caucasian patients treated in routine clinical
Externí odkaz:
https://doaj.org/article/d7176d935e0a4a359302b37df3fb11e5
Autor:
Mariann Szabó, Veronika Sárosi, Zoltán Balikó, Kornélia Bodó, Nelli Farkas, Tímea Berki, Péter Engelmann
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background Based on the phenotypic and functional characteristics unconventional T-lymphocytes such as invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells link the innate and adaptive immune responses. Up
Externí odkaz:
https://doaj.org/article/90d80b9b2dce4f1a9f01587f96e68480
Autor:
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi-Tóth, Judit Moldvay
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Objective: While Hungary is often reported to have the highest incidence and mortality rates of lung cancer, until 2018 no nationwide epidemiology study was conducted to confirm these trends. The objective of this study was to estimate the occurrence
Externí odkaz:
https://doaj.org/article/6ffedb1a368b4ae282becbb0fa3e0fa8
Autor:
Zoltán Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Kata Knollmajer, Máté Várnai, Krisztina Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, István Kenessey, András Weber, Péter Nagy, Petra Freyler-Fadgyas, Miklós Szócska, Péter Szegner, Lászlóné Hilbert, Gabriella Branyiczkiné Géczy, György Surján, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy, Zoltán Polányi
Publikováno v:
Frontiers in oncology. 12
ObjectiveThe Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed LC with those who were